Crossmark

Integrative multimodal transcriptomics identifies a cancer-associated fibroblast membrane signature for predicting prognosis and therapeutic response in pancreatic ductal adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s00109-026-02669-7

Published Online: 2026-04-06

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhuang, Leshi https://orcid.org/0009-0002-7236-5546
Zhang, Wei https://orcid.org/0009-0007-6333-4138
Wu, Jun https://orcid.org/0000-0002-1717-0378
Cao, Jian https://orcid.org/0009-0004-0932-8632
Feng, Liang https://orcid.org/0009-0007-3070-8148
Cao, Shubo https://orcid.org/0009-0007-4881-3210
License Information

Text and Data Mining valid from 2026-04-06

Version of Record valid from 2026-04-06
More Information

Article History

Received: 30 October 2025

Revised: 25 March 2026

Accepted: 26 March 2026

First Online: 6 April 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.